News Sentiment

CYAD sentiment intelligence

Celyad Oncology SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 54 Balanced news tone 6 relevant articles
Exchange BRU Belgium
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.22 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-5.5% over one week, -15.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Celyad Oncology raises €500,000 from Fortress Investment Group By Investing.com

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -5.5% Price reacting lower
Trend fit Trend inactive -15.3% over four weeks
Fair value -43.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Business Wire 2
Stock Titan 2
Investing.com Nigeria 1
Fierce Biotech 1

Event Lens

What the news is about

Classified themes
Market update 5
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6